BioActor and Pixience announce the start of a collaboration to test and validate an innovative skin imaging and testing technology in the context of a clinical study with a nutritional bioactive.
Pixience has developed an innovative skin image capturing device (C-Cube) and image analysis software (QuickScale) for the evaluation of several skin parameters, including the evaluation of 3D images.
BioActor has expertise in the clinical validation of health effects of natural compounds and is now setting-up a clinical testing platform around nutritional actives for skin health.
Pixience is developing the C-Cube Clinical Edition and BioActor will carry-out beta testing of the Clinical Edition in a new clinical study on an oral nutritional product. Pixience will provide technical assistance to BioActor for the skin image analysis in this new clinical study.
BioActor tests all of its products in scientifically robust human intervention studies, working with partners like Pixience
- Hans van der Saag, CEO of BioActor
Sebastien Mangeruca, CEO of Pixience said: “We have initially developed our C-Cube and QuickScale suite of technologies for the evaluation of topical cosmetic products. BioActor’s experience in running clinical studies for nutrition and its active programme around nutrition and skin health, makes them an ideal partner for testing and validating of our C-Cube Clinical Edition for nutrition studies”.
Hans van der Saag, CEO of BioActor said: “BioActor is delighted to work with Pixience, as Pixience has developed a best in class skin imaging and analysis technology that will allow us to further improve our skin health for nutrition platform”.
Van der Saag continued: “BioActor wants to bring clinically backed innovation to the nutrition industry. BioActor tests all of its products in scientifically robust human intervention studies, working with partners like Pixience and the Department of Health and Nutrition of Maastricht University.”
